Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

OncoSec Medical Inc ONCSQ

OncoSec Medical Incorporated is a late-stage immuno-oncology company. The Company is focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics delivered by electroporation (EP) to stimulate and augment anti-tumor immune responses for the treatment of cancers. Its core technology, ImmunoPulse, is a drug-device therapeutic modality platform comprised of an OncoSec Medical System EP device (the OMS EP Device) and a DNA plasmid delivery and application method that enables transient expression of recombinant therapeutic molecules in cells. The OMS EP Device is designed to promote cellular uptake of plasmid DNA injected directly into solid tumors to allow subsequent expression of the encoded therapeutic protein. The OMS EP Device can be adapted to treat different tumor types and consists of an electrical pulse generator and a disposable applicator. Its lead product candidate, tavokinogene telseplasmid (TAVO), is a plasmid encoding human interleukin-12.


GREY:ONCSQ - Post by User

Post by Stockqueen77on Aug 06, 2021 2:11am
162 Views
Post# 33662183

AVTAR DHILLION ARRESTED

AVTAR DHILLION ARRESTED
A cannabis and biotechnology entrepreneur was arrested and charged with securities fraud over his secret sale of shares in two companies in which he served as board chairman. Avtar S. Dhillon, 60, executive chairman of medical marijuana firmEmerald Health Therapeutics Inc., was arrested Wednesday on charges brought by federal prosecutors in Boston, who said he made more than $2 million from the scheme. Dhillon, a Canadian national living in California, will make his initial appearance in federal court in Boston at a later date. A lawyer for Dhillon couldnt immediately be identified. Vancouver-based Emerald Health declined to comment on Dhillons arrest. According to the government, Dhillon concealed from regulators his ownership of millions of shares inArch Therapeutics Inc.andOncoSec Medical Inc., two microcap biotech firms. He was board chairman at Arch from 2013 to 2018 and OncoSec from 2011 to 2020. Dhillon and a co-conspirator made false and misleading representations in order to deposit and then sell the shares in the open market to unsuspecting investors, the government said. From 2005 to 2009, Dhillon was chief executive officer ofInovio Pharmaceuticals Inc.
<< Previous
Bullboard Posts
Next >>